Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases
Journal of Contemporary Brachytherapy · 2022 · 14 (4) · 364-369
DOI: 10.5114/jcb.2022.119515 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Contemporary Brachytherapy, 2022. Verfasst von Maximilian Thormann und 7 weiteren Autor:innen. Beteiligte Einrichtung: University Clinic for Radiology and Nuclear Medicine, University Hospital Magdeburg, Magdeburg, Germany. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Clinic for Radiology and Nuclear Medicine, University Hospital Magdeburg, Magdeburg, Germany.
- Clinic for Radiation Oncology, University Hospital Magdeburg, Magdeburg, Germany.
Zitieren
APA
Thormann, M., Heitmann, F., March, C., Pech, M., Hass, P., Surov, A., Damm, R., & Omari, J. (2022). Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases. Journal of Contemporary Brachytherapy, 14(4), 364-369. https://doi.org/10.5114/jcb.2022.119515
Vancouver
Thormann M, Heitmann F, March C, Pech M, Hass P, Surov A, et al. Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases. Journal of Contemporary Brachytherapy. 2022;14(4):364-369. doi:10.5114/jcb.2022.119515
BibTeX
@article{Thormann2022,
author = {Thormann, Maximilian and Heitmann, Franziska and March, Christine and Pech, Maciej and Hass, Peter and Surov, Alexey and Damm, Robert and Omari, Jazan},
title = {Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases},
journal = {Journal of Contemporary Brachytherapy},
year = {2022},
volume = {14},
number = {4},
pages = {364--369},
doi = {10.5114/jcb.2022.119515}
}
EUVIMED